(Q35131864)

6 August 2017

1 reference

title

Immunology of viral respiratory tract infection in infancy (English)

1 reference

6 August 2017

1 reference

1 reference

James E Crowe

1

0 references

author name string

John V Williams

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

Paediatric Respiratory Reviews

6 August 2017

1 reference

6 August 2017

4

1 reference

6 August 2017

2

1 reference

6 August 2017

112-119

1 reference

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Metapneumovirus and acute wheezing in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Human metapneumovirus as a cause of community-acquired respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Analysis of the genomic sequence of a human metapneumovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Spectrum of clinical illness in hospitalized patients with "common cold" virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Neonatal respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Cellular and antibody response to respiratory syncytial (rs) virus in human colostrum, maternal blood, and cord blood

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Breast-feeding protects against respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

The Immunologic Response to Infection with Respiratory Syncytial Virus in Infants

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Genetic and structural determinants of virus neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

IFNs activate toll-like receptor gene expression in viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

What have we learned from the Tucson Children's Respiratory Study?

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900033-2

7 January 2021

10.1016/S1526-0542(03)00033-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12758048